Journal articleEur Rev Med Pharmacol Sci2021
Combination therapy with interleukin-15 and metformin as a synergistic treatment for pancreatic cancer.
- Journal
- Eur Rev Med Pharmacol Sci
- Published
- 1 August 2021
- Citations
- 3
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Objective To investigate the efficacies and mechanisms of combination therapy with interleukin-15 (IL-15) and metformin (Met) on suppressing pancreatic cell proliferation and protecting Panc02-bearing mice. Materials and methods MTT assays were applied to assess the inhibitory effects of IL-15 combined Met or Met and IL-15 alone on proliferation of normal HPDE6-C7 and Panc02 cells. … Excerpt only: this text is the publisher’s. Read it in full at the source.